Next Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Definition and prevalence
- Etiopathogenesis
- Endocrine system
- Skin
- Muscle
- Bone
- FD/MAS etiopathogenesis and histopathology
- Periosteal bone is not primarily affected
- Osteogenic cells form thin, irregular bone trabeculae
- Dysplastic bone irregularly replaces normal bone
- Dysplastic bone and fibrous tissue are highly vascularized
- Fibroblast growth factor 23 (FGF23)
- Skeletal involvement in FD/MAS
- Progression of skeletal lesions in FD/MAS
- FD/MAS malignant transformation
- FD/MAS clinical manifestations
- Imaging in FD/MAS: radiology and CT scan
- Imaging in FD/MAS: MRI and Tc bone scan
- Pain in FD/MAS
- Typical lower limb deformities: 6 typical deformities
- Typical lower limb deformities: other
- Worsening of skeletal deformities in FD/MAS
- Fractures in FD/MAS
- Scoliosis in FD/MAS
- FD/MAS diagnosis (1)
- FD/MAS diagnosis (2)
- Medical treatment: bisphosphonates
- Medical treatment: denosumab
- Denosumab: clinical trial
- Denosumab: mouse models
- Medical treatment: denosumab and zoledronic acid
- Medical treatment: burosumab
- Surgical treatment of FD/MAS: basic principles
- Two stage surgery in severe coxa vara ≤90o
- Intramedullary nailing (IN) for lower limb FD
- Titanium elastic nails (TENs)
- Complementary surgery: performed during growth in 37% of cases
- Evaluation scale at follow-up
- Results (IN in child with FD)
- Good results: 16 years follow-up
- Poor results
- Complications
- IN in patients with previous unsuccessful treatment
- Results (IN in adults with previous unsuccessful treatment)
- Results: good and poor
- Complications
- Conclusions: etiopathogenesis
- Conclusions: diagnosis and treatment
- Conclusions: surgery
- Conclusions: the future
- Acknowledgements
Topics Covered
- McCune-Albright Syndrome (MAS)
- Fibrous Dysplasia (FD)
- Etiopathogenesis of MAS
- Skeletal involvement in FD/MAS
- Imaging FD/MAS
- FD/MAS diagnosis
- FD/MAS medical treatment
- Surgical treatment of FD/MAS
- Intramedullary Nailing (IN)
Links
Categories:
Therapeutic Areas:
Talk Citation
Ippolito, E. and Lardo, D. (2024, July 31). Fibrous dysplasia of bone in McCune-Albright syndrome: pathophysiology, clinical aspects and treatment [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 12, 2025, from https://doi.org/10.69645/BUOJ6752.Export Citation (RIS)
Publication History
- Published on July 31, 2024
Financial Disclosures
- There are no financial interests to disclose.
- There are no financial interests to disclose.
Fibrous dysplasia of bone in McCune-Albright syndrome: pathophysiology, clinical aspects and treatment
Published on July 31, 2024
22 min
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
Fibrous Dysplasia of Bone in
McCune-Albright Syndrome.
Pathophysiology, Clinical
Aspects, and Treatment
by Ernesto Ippolito,
Professor Emeritus of
Orthopedic Surgery,
University of Rome,
Tor Vergata, Italy;
and Davide Lardo,
senior resident,
Department of
Orthopedic Surgery,
University of Rome, Tor Vergata,
and Senior Medical Officer of
the Military Hospital of Rome,
Attilio Frigeri, Italy.
0:37
Definition and prevalence.
McCune-Albright syndrome is
a rare genetic
pathologic condition
affecting endocrine
glands, skin, and bone.
0:51
Etiopathogenesis.
The mutated GNAS
gene overstimulates
the production of
intracellular cAMP in
endocrine glands,
skin melanocytes,
and osteogenic cells.
The mutation is post-zygotic,
producing a mosaic
state in which
both normal and pathologic
tissues coexist.
1:22
Endocrine system.
Gonads, thyroid, pituitary,
and adrenal glands are
the most frequently
affected with
the overproduction of
their specific hormones.
1:36
Skin.
Melanocytes are overstimulated
with the formation of
cafe-au-lait skin macules.
Muscle.
Hide